Binding of temoporfin to the lipoprotein fractions of human serum.
The binding of a new photosensitizer, temoporfin, to human serum lipoproteins was investigated. [14C]-Temoporfin (0.1-10 micrograms ml-1) was incubated with human serum for 30 min at room temperature or for 20 h at 4 degrees C, prior to stepwise density flotation to separate the lipoprotein fractions. The distribution of the drug was independent of the initial concentration or time and temperature of the incubation. The proportion of temoporfin in each fraction was: very low density lipoprotein 6%, low density lipoprotein 22%, lipoprotein(a) 17%, high density lipoprotein 39% and lipoprotein deficient serum 16%. Autoradiography of agarose gels showed that the drug was associated with the lipoprotein in the fractions. Fractionation of plasma samples collected from a patient after an intravenous infusion of temoporfin revealed a binding profile similar to that obtained in the in vitro study.
Michael-Titus
A T
AT
Department of Pharmacology, Queen Mary and Westfield College, London, UK.
Whelpton
R
R
Yaqub
Z
Z
D000328:Adult; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood / Q000378:metabolism*; D008075:Lipoproteins, HDL / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism; D008079:Lipoproteins, VLDL / Q000378:metabolism; D008297:Male; D008652:Mesoporphyrins / Q000378:metabolism*; D008875:Middle Aged; D017319:Photosensitizing Agents / Q000378:metabolism; D011838:Radiation-Sensitizing Agents / Q000378:metabolism*
D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D008652:Mesoporphyrins; D017319:Photosensitizing Agents; D011838:Radiation-Sensitizing Agents; C072269:temoporfin